BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22653283)

  • 1. Dynamic contrast-enhanced 3-T MR imaging in cervical cancer before and after concurrent chemoradiotherapy.
    Kim JH; Kim CK; Park BK; Park SY; Huh SJ; Kim B
    Eur Radiol; 2012 Nov; 22(11):2533-9. PubMed ID: 22653283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of early response to concurrent chemoradiotherapy in cervical cancer: value of diffusion-weighted and dynamic contrast-enhanced MR imaging.
    Park JJ; Kim CK; Park SY; Simonetti AW; Kim E; Park BK; Huh SJ
    Magn Reson Imaging; 2014 Oct; 32(8):993-1000. PubMed ID: 24970025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
    Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
    Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
    Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
    Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.
    Yang W; Qiang JW; Tian HP; Chen B; Wang AJ; Zhao JG
    Eur Radiol; 2018 Jan; 28(1):437-445. PubMed ID: 28779395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
    Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood oxygenation level-dependent MR imaging as a predictor of therapeutic response to concurrent chemoradiotherapy in cervical cancer: a preliminary experience.
    Kim CK; Park SY; Park BK; Park W; Huh SJ
    Eur Radiol; 2014 Jul; 24(7):1514-20. PubMed ID: 24763631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Xu C; Sun H; Du S; Xin J
    Eur J Radiol; 2019 Aug; 117():1-8. PubMed ID: 31307633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.
    Sun NN; Ge XL; Liu XS; Xu LL
    Radiol Med; 2020 Feb; 125(2):165-176. PubMed ID: 31605354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.
    Zheng X; Guo W; Dong J; Qian L
    Magn Reson Imaging; 2020 Oct; 72():159-166. PubMed ID: 32621877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of therapeutic response to concurrent chemoradiotherapy in patients with cervical cancer using diffusion-weighted MR imaging.
    Kim HS; Kim CK; Park BK; Huh SJ; Kim B
    J Magn Reson Imaging; 2013 Jan; 37(1):187-93. PubMed ID: 23018989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited accuracy of DCE-MRI in identification of pathological complete responders after chemoradiotherapy treatment for rectal cancer.
    Gollub MJ; Tong T; Weiser M; Zheng J; Gonen M; Zakian KL
    Eur Radiol; 2017 Apr; 27(4):1605-1612. PubMed ID: 27436029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative free-breathing dynamic contrast-enhanced MRI in hepatocellular carcinoma using gadoxetic acid: correlations with Ki67 proliferation status, histological grades, and microvascular density.
    Chen J; Chen C; Xia C; Huang Z; Zuo P; Stemmer A; Song B
    Abdom Radiol (NY); 2018 Jun; 43(6):1393-1403. PubMed ID: 28939963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.
    Xu L; Ge X; Sun N; Liu X
    Acta Radiol; 2020 Oct; 61(10):1316-1325. PubMed ID: 32053003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.
    Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic contrast-enhanced MR imaging pharmacokinetic parameters as predictors of treatment response of brain metastases in patients with lung cancer.
    Kuchcinski G; Le Rhun E; Cortot AB; Drumez E; Duhal R; Lalisse M; Dumont J; Lopes R; Pruvo JP; Leclerc X; Delmaire C
    Eur Radiol; 2017 Sep; 27(9):3733-3743. PubMed ID: 28210799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.
    Feng Y; Liu H; Ding Y; Zhang Y; Liao C; Jin Y; Ai C
    Tumori; 2020 Apr; 106(2):155-164. PubMed ID: 31736439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumours: comparison of quantitative and semi-quantitative analysis.
    Galbraith SM; Lodge MA; Taylor NJ; Rustin GJ; Bentzen S; Stirling JJ; Padhani AR
    NMR Biomed; 2002 Apr; 15(2):132-42. PubMed ID: 11870909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging.
    Tokuda J; Mamata H; Gill RR; Hata N; Kikinis R; Padera RF; Lenkinski RE; Sugarbaker DJ; Hatabu H
    J Magn Reson Imaging; 2011 Apr; 33(4):968-73. PubMed ID: 21448965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.